ONCO vs IMMX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 21, 2026

ONCO

47.0
AI Score
VS
ONCO Wins

IMMX

36.6
AI Score

Investment Advisor Scores

ONCO

47score
Recommendation
HOLD

IMMX

37score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric ONCO IMMX Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -83.9% 0.0% IMMX
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 47.0/100 36.6/100 ONCO
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

ONCO 1M: -22.8% · 3M: -45.2% IMMX 1M: +66.7% · 3M: +61.2%

Current Technical Phase

ONCO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.3%), weak momentum, RSI 37

RSI (14): 37.3 · Price: $0.64

IMMX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.4% over 20 days), RSI 73

RSI (14): 72.6 · Price: $14.07

Fundamentals Snapshot

Metric ONCO IMMX
Market Cap
Forward P/E 0.0 -15.6
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth -0.8% 0.0%
Gross Margin 0.8%
Operating Margin -131.1% 0.0%
EPS 749.08 -0.94
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ONCO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.